LBA36Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study
Ledermann, J A, Shapira-Frommer, R, Santin, A, Lisyanskaya, A S, Pignata, S, Vergote, I, Raspagliesi, F, Sonke, G S, Birrer, M J, Provencher, D M, Sehouli, J, Colombo, N, González-Martín, A, Oaknin, AVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.043
Date:
October, 2018
File:
PDF, 76 KB
2018